| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2973327 | The Journal of Heart and Lung Transplantation | 2006 | 6 Pages |
Abstract
The development of RHF after LVAD insertion confers significant morbidity and mortality. Judicious application of inotropes and pulmonary vasodilators and timely RVAD insertion, if necessary, should be maintained. Further investigations evaluating pre- and intra-operative risk factors for the development of RHF are warranted.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Nicholas C. MD, Veli K. MD, Michelle BS, Joy BS, Kurt H. ScB, Michael S. Aboodi, Mehmet C. MD, Yoshifumi MD, PhD,